申请人:Orion Corporation
公开号:US10336697B2
公开(公告)日:2019-07-02
The present invention provides novel spiro[cyclobutane-1,3′-indolin]-2′-one derivatives of formula (I)
in which Cy, R1, R2, R4, L, and m have the meaning given in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula (I) are useful as bromodomain inhibitors in the treatment or prevention of diseases or disorders where bromodomain inhibition is desired.
本发明提供了式 (I) 的新型螺[环丁烷-1,3′-吲哚啉]-2′-酮衍生物
其中 Cy、R1、R2、R4、L 和 m 具有说明书中给出的含义,以及它们的药学上可接受的盐。式(I)化合物可作为溴链抑制剂用于治疗或预防需要溴链抑制的疾病或失调。